Ubs Group Ag Rani Therapeutics Holdings, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 15,709 shares of RANI stock, worth $22,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,709
Previous 3,000
423.63%
Holding current value
$22,935
Previous $11,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.76 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.04 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$720,6321.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$654,7980.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$442,0040.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $35.8M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...